TLR4 mediates post-traumatic depression via kynurenine pathway activation in a murine traumatic brain injury model

Introduction: Traumatic brain injury (TBI) is a major risk factor for major depressive disorder (MDD), yet the underlying mechanisms remain poorly defined. This study demonstrates that toll-like receptor 4 (TLR4) activation drives depressive-like behaviors through dysregulation of the kynurenine pathway (KP) in a murine model of moderate TBI. Methods and Results: : LPS-stimulated BV2 microglia showed increased IDO1/KMO/QUIN expression, which was abolished by TAK-242 pretreatment. Conclusion: Our findings establish a novel TLR4-KP-QUIN pathway as a critical mediator of post-TBI depression, providing a mechanistic basis for TLR4-targeted therapies. In addition to neuroinflammatory effects, this work mainly mediates dysregulation of TBI-related neuropsychiatric sequelae through metabolism, highlighting TLR4 inhibition as a promising strategy for mitigating chronic depressive outcomes after brain injury.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-04-15
DOI
https://doi.org/10.3389/fphar.2026.1744031
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TLR4 mediates post-traumatic depression via kynurenine pathway activation in a murine traumatic brain injury model

Yan Peng, Ruo‐Bing Gao, Chang-Hong Li, Bo Wang et al.
Frontiers in Pharmacology
Tryptophan and brain disorders
article

TLR4 mediates post-traumatic depression via kynurenine pathway activation in a murine traumatic brain injury model

Yan Peng, Ruo‐Bing Gao, Chang-Hong Li, Bo Wang, Ping Li, Xiao-Hui Li, Ke Chen
article en

Abstract

Introduction: Traumatic brain injury (TBI) is a major risk factor for major depressive disorder (MDD), yet the underlying mechanisms remain poorly defined. This study demonstrates that toll-like receptor 4 (TLR4) activation drives depressive-like behaviors through dysregulation of the kynurenine pathway (KP) in a murine model of moderate TBI. Methods and Results: : LPS-stimulated BV2 microglia showed increased IDO1/KMO/QUIN expression, which was abolished by TAK-242 pretreatment. Conclusion: Our findings establish a novel TLR4-KP-QUIN pathway as a critical mediator of post-TBI depression, providing a mechanistic basis for TLR4-targeted therapies. In addition to neuroinflammatory effects, this work mainly mediates dysregulation of TBI-related neuropsychiatric sequelae through metabolism, highlighting TLR4 inhibition as a promising strategy for mitigating chronic depressive outcomes after brain injury.

Frontiers in PharmacologyVol. 17
Army Medical University (CN), Anhui Medical University (CN), Daping Hospital (CN), Chongqing Medical University (CN)
Openalex Percentile: Top 22%
Tryptophan and brain disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.